Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-014725
Filing Date
2017-02-27
Accepted
2017-02-27 16:14:25
Documents
1
Period of Report
2017-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6672
  Complete submission text file 0001209191-17-014725.txt   8018
Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. STE S-7 MILFORD MA 01757
Business Address
Eichler Kurt M (Reporting) CIK: 0001424591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 17641814

Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations